Regulatory Affairs and Global Policy

Global drug development is only as strong as its regulatory strategy. Regulatory Affairs & Global Policy focuses on harmonized pathways, policy evolution, and compliance frameworks that enable efficient, lawful access to global markets. This session equips regulatory professionals, scientists, and quality experts with the insight to navigate the increasingly complex ecosystem of health authorities, including FDA, EMA, MHRA, PMDA, NMPA, and WHO prequalification systems. Attendees will understand how early regulatory intelligence drives faster submissions, lower risk, and stronger agency rapport.

Topics include dossier planning (CTD/eCTD), procedural choices such as centralized vs. decentralized routes, and managing variations and lifecycle updates post-approval. The session also covers regional divergences in labeling, pharmacovigilance, pediatric and orphan incentives, and digital health regulations. The discussion highlights how global policy is evolving—through ICH modernization (Q8–Q14, M10, E17) and data transparency frameworks—to support more consistent, risk-based evaluations.

Participants will gain actionable insights into regulatory interactions, briefing document preparation, and managing authority queries under accelerated review timelines. This is also where industry meets policy—examining how harmonization efforts, mutual recognition agreements, and reliance procedures are shaping the global regulatory environment. For professionals attending a Pharmaceutical Conference, this track provides a practical lens into strategic submissions, inspection preparedness, and regulatory innovation. The rise of global health regulatory policy—including initiatives such as WHO ML4H and African Medicines Agency (AMA)—is also covered, emphasizing equitable access and ethical governance in cross-border approvals.

By blending technical mastery with strategic foresight, this session empowers organizations to align scientific evidence, documentation, and policy expectations. It’s ideal for professionals involved in CMC, clinical, quality, and compliance roles seeking a comprehensive roadmap to global registration success.